Dr. Gerke’s current research is directed at evaluating the role of environmental exposures in the development of interstitial lung diseases such as pulmonary fibrosis and sarcoidosis.
Selected Publications:
1. Hagner MD, Miller A, De la Serna S, Arakkal A, Cavanaugh J, Pezzulo A, Hamzeh N, Polgreen P, Gerke A. The Diagnostic Course of Sarcoidosis: A Population-Based Study Highlighting Risk Factors for a Delay in Diagnosis. Sarcoidosis Vasc Diffuse Lung Dis. 2026 Jun 22;43(2):18607. doi:10.36141/svdld.2026.18607. PMID:42329014; PMCID:PMC13359006.
2. Wells AU, Lower EE, Baughman RP, Culver DA, Judson MA, Bonham CA, Gerke AK, et al. A paradigm shift in corticosteroid therapy for sarcoidosis. Lancet Respir Med. 2026 Apr;14(4):363-374. doi:10.1016/S2213-2600(25)00338-8. PMID:41207318; PMCID:PMC13397509.
3. Stapleton EM, Metwali N, Shlossman M, Wendt L, Pezzulo AA, Hamzeh NY, Comellas AP, Thorne PS, Gerke AK. Residential fungal β-(1,3)-D-glucan exposure is associated with decreased pulmonary function in fibrotic pulmonary sarcoidosis. Res Sq. 2024 Oct 22:rs.3.rs-5220174. PMID:39502781; PMCID:PMC11537350.
4. Wang S, Laageide L, Phan V, Rosenbach M, Gerke AK, Wanat KA. Use of registry surveys in cutaneous sarcoidosis. J Am Acad Dermatol. 2024 Jun;90(6):1294-1296. doi:10.1016/j.jaad.2024.02.023. PMID:38395226.
5. Gerke AK. Treatment of Granulomatous Inflammation in Pulmonary Sarcoidosis. J Clin Med. 2024 Jan 27;13(3):738. doi:10.3390/jcm13030738. PMID:38337432; PMCID:PMC10856377.
6. Chung H, Hanken K, Gerke AK, Lund BC. Montelukast and risk for antidepressant treatment failure. J Psychosom Res. 2023 Jan;164:111075. doi:10.1016/j.jpsychores.2022.111075. PMID:36368225.
7. Fox CW, Khaw CL, Gerke AK, Lund BC. Montelukast and neuropsychiatric events. J Asthma. 2022 Dec;59(12):2360-2366. doi:10.1080/02770903.2021.2018705. PMID:34979844.
8. Simmering J, Stapleton EM, Polgreen PM, Kuntz J, Gerke AK. Patterns of medication use and imaging following initial diagnosis of sarcoidosis. Respir Med. 2021 Nov-Dec;189:106622. PMID:34600163; PMCID:PMC10918686.
9. Zhou Y, Gerke AK, Lower EE, et al. The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study. Respir Med. 2021 Oct;187:106564. PMID:34391118; PMCID:PMC9999732.
10. Priya S, Aggarwal T, Ward C, Bathla G, Jacob M, Gerke A, Hoffman EA, Nagpal P. Radiomics side experiments and DAFIT approach in identifying pulmonary hypertension using Cardiac MRI derived radiomics based machine learning models. Sci Rep. 2021 Jun 16;11(1):12686. PMID:34135418; PMCID:PMC8209219.
11. Priya S, Aggarwal T, Ward C, Bathla G, Jacob M, Gerke A, Hoffman EA, Nagpal P. Radiomics Detection of Pulmonary Hypertension via Texture-Based Assessments of Cardiac MRI. J Clin Med. 2021 Apr 28;10(9):1921. PMID:33925262; PMCID:PMC8125238.
12. Miller AC, Arakkal AT, Koeneman S, Cavanaugh JE, Gerke AK, Hornick DB, Polgreen PM. Incidence, duration and risk factors associated with delayed and missed diagnostic opportunities related to tuberculosis. BMJ Open. 2021 Feb 18;11(2):e045605. PMID:33602715; PMCID:PMC7896623.
13. Philibert R, Mills JA, Long JD, Salisbury SE, Comellas A, Gerke A, Dawes K, Vander Weg M, Hoffman EA. The Reversion of cg05575921 Methylation in Smoking Cessation. Genes (Basel). 2020;11(12):1415. PMID:33260961; PMCID:PMC7760261.
14. Gerke AK. Treatment of Sarcoidosis: A Multidisciplinary Approach. Front Immunol. 2020 Nov 19;11:545413. PMID:33329511; PMCID:PMC7732561.
15. Vargas Buonfiglio LG, Vanegas Calderon OG, Cano M, Simmering JE, Polgreen PM, Zabner J, Gerke AK, Comellas AP. Seasonal Antimicrobial Activity of the Airway. Nutrients. 2020;12(9):2602. PMID:32867053; PMCID:PMC7551279.
16. Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, Abston E, Bernstein RC, Blankstein R, Chen ES, Culver DA, Drake W, Drent M, Gerke AK, Ghobrial M, Govender P, Hamzeh N, James WE, Judson MA, Kellermeyer L, Knight S, Koth LL, Poletti V, Raman SV, Tukey MH, Westney GE, Baughman RP. Diagnosis and Detection of Sarcoidosis. Am J Respir Crit Care Med. 2020;201(8):e26-e51. PMID:32293205; PMCID:PMC7159433.
17. Harper LJ, Gerke AK, Wang XF, et al. Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis. Am J Respir Crit Care Med. 2020;201(8):955-964. PMID:31825646; PMCID:PMC7924656.